SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 102 filers reported holding SYROS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 7.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | -100.0% | 140 | -63.6% | 0.00% | – |
| Q4 2021 | $1,000 | -99.6% | 385 | -99.1% | 0.00% | – |
| Q3 2021 | $255,000 | +3.2% | 45,117 | -0.5% | 0.00% | – |
| Q2 2021 | $247,000 | +43.6% | 45,358 | +96.7% | 0.00% | – |
| Q1 2021 | $172,000 | +561.5% | 23,054 | +856.6% | 0.00% | – |
| Q4 2020 | $26,000 | – | 2,410 | +2670.1% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 87 | -85.0% | 0.00% | – |
| Q3 2019 | $6,000 | 0.0% | 580 | -18.3% | 0.00% | – |
| Q2 2019 | $6,000 | +50.0% | 710 | +36.8% | 0.00% | – |
| Q1 2019 | $4,000 | -20.0% | 519 | -51.4% | 0.00% | – |
| Q4 2018 | $5,000 | -72.2% | 1,068 | -31.4% | 0.00% | – |
| Q3 2018 | $18,000 | +100.0% | 1,557 | +68.1% | 0.00% | – |
| Q2 2018 | $9,000 | -71.0% | 926 | -62.2% | 0.00% | -100.0% |
| Q1 2018 | $31,000 | -73.0% | 2,449 | -79.3% | 0.00% | -80.0% |
| Q4 2017 | $115,000 | – | 11,837 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|